Effect of Face Yoga on Mimic Muscles

January 3, 2025 updated by: Hazel Çelik Güzel, Bandırma Onyedi Eylül University

The Effect of Facial Yoga on Tonus, Stiffness and Elasticity of Mimic Muscles

This study aimed to investigate the effect of facial yoga on tonus, stiffness and elasticity of facial muscles.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This study was conducted on healthy volunteers aged 25-50 between June 2024 and January 2025. In the participants who agree to participate in the study, a descriptive data form and myotone evaluations of facial muscles will be performed. Measurements will be carried out immediately after the participants are recruited and at the end of the 8-week facial yoga programme.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Balikesir, Turkey
        • Bandırma Onyedi Eylül University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Healthy female volunteers

Description

Inclusion Criteria:

  • Individuals between 25-50 years of age whose voluntary consent was obtained

Exclusion Criteria:

  • Botox application to the facial area in the last 6 months,
  • Regular use of analgesics and anti-inflammatories,
  • The presence of infection or tumoural structures within the structures in the facial region,
  • With TMJ disc displacement and joint degeneration,
  • Cervical or TMJ fracture, systemic disease, musculoskeletal problem with evidence of specific pathological condition,
  • Any surgical operation related to cervical or TMJ problem,
  • Less than 6 months of cervical or TMJ-related physiotherapy and rehabilitation services,
  • The one with facial paralysis,
  • Participants with diagnosed psychiatric illness will not be included in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Evaluation of the mimic muscles tone
Time Frame: June 2024- August 2024
Myoton®PRO (Myoton Ltd, Myoton AS, Estonia) was used to objectively evaluate of the participants' facial muscles tone. The frontalis, corrugator supercili, orbicularis oculi, nasalis, orbicularis oris, mentalis and buccinator muscles, as well as masseter, temporal and digastric muscles were evaluated bilaterally in the sitting position.
June 2024- August 2024
Evaluation of the mimic muscles stiffness
Time Frame: June 2024- August 2024
Myoton®PRO (Myoton Ltd, Myoton AS, Estonia) was used to objectively evaluate of the participants' facial muscles stiffness. The frontalis, corrugator supercili, orbicularis oculi, nasalis, orbicularis oris, mentalis and buccinator muscles, as well as masseter, temporal and digastric muscles were evaluated bilaterally in the sitting position.
June 2024- August 2024
Evaluation of the mimic muscles elasticity
Time Frame: June 2024- August 2024
Myoton®PRO (Myoton Ltd, Myoton AS, Estonia) was used to objectively evaluate of the participants' facial muscles elasticity. The frontalis, corrugator supercili, orbicularis oculi, nasalis, orbicularis oris, mentalis and buccinator muscles, as well as masseter, temporal and digastric muscles were evaluated bilaterally in the sitting position.
June 2024- August 2024

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Assessing mimic muscle tone after exercising
Time Frame: October 2024- December 2024
After the exercise program, the participants' facial muscles tone evaluated by Myoton Pro. The frontalis, corrugator supercili, orbicularis oculi, nasalis, orbicularis oris, mentalis and buccinator muscles, as well as masseter, temporal and digastric muscles were evaluated bilaterally in the sitting position.
October 2024- December 2024
Assessing mimic muscle stiffness after exercising
Time Frame: October 2024- December 2024
After the exercise program, the participants' facial muscles stiffness evaluated by Myoton Pro. The frontalis, corrugator supercili, orbicularis oculi, nasalis, orbicularis oris, mentalis and buccinator muscles, as well as masseter, temporal and digastric muscles were evaluated bilaterally in the sitting position.
October 2024- December 2024
Assessing mimic muscle elasticity after exercising
Time Frame: October 2024- December 2024
After the exercise program, the participants' facial muscles elasticity evaluated by Myoton Pro. The frontalis, corrugator supercili, orbicularis oculi, nasalis, orbicularis oris, mentalis and buccinator muscles, as well as masseter, temporal and digastric muscles were evaluated bilaterally in the sitting position.
October 2024- December 2024

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Bandırma Onyedi Eylül University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
June 1, 2024

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
January 1, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
January 1, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
January 3, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 3, 2025

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 25, 2025

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 25, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 3, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
January 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 2024 -113

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings